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hicago, Illinois
mprovements in prevention and treatment have resulted in
triking reductions in age-adjusted mortality rates related to
ardiovascular disease during the past several decades (1).
hese impressive results have been catalyzed by new therapies,
any of which have been substantiated in large-scale multi-
enter clinical trials that provide the foundation for evidence-
ased practice guidelines. During the same time period, diag-
ostic testing has proliferated at an astonishing rate. Stress
maging tests in particular have increased at an annual rate of
.1% since 1993 in individuals covered by Medicare (2). It is
stimated that nearly 8 million single-photon emission com-
uted tomography (SPECT) studies are now performed an-
ually in the U.S., compared with 4 million in 1998 (3).
iagnostic imaging has increased more rapidly than any other
omponent of medical care (4). The increase in cardiovascular
maging procedures is not related to changes in disease prev-
lence or severity, and it has been difficult to tie the increase in
maging to improved health outcomes. It is not surprising that
maging is now under close scrutiny by the payers of health
are. Does the proliferation of diagnostic imaging represent
dded value or added cost?
See page 1283
Unlike prevention and treatment strategies supported by
vidence-based practice guidelines, the evidence base for im-
ging is anecdotal, fragmented, and lacking in prospective
linical trials. Thus, as the field of cardiovascular medicine
volves from clinical practice guidelines to clinical performance
easures (5,6), metrics to measure quality of imaging will be
lusive. It is rarely possible to demonstrate that performance of
n imaging test leads directly to improved health outcomes.
ather than outcome measures, quality might be assessed by
easures of laboratory structure, such as equipment, staff
raining, and laboratory protocols, or measures of laboratory
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Division of Cardiology, Northwestern University Feinberg School ofr
edicine and the Bluhm Cardiovascular Institute Northwestern Memorial Hospital,
hicago, Illinois.rocess, such as image acquisition, image interpretation, and
eporting. More importantly, one might measure patient se-
ection, as this key variable will impact directly on subsequent
linical management, downstream testing procedures, and
osts (7).
Against this backdrop, the American College of Cardi-
logy has provided the needed leadership in addressing
hese quality issues by spearheading the recent development
f appropriateness criteria for cardiovascular imaging (8,9),
hich are designed to define the appropriate test for the
ppropriate indication in the appropriate patient. The first
uch criteria were developed for SPECT myocardial perfu-
ion imaging (MPI) in conjunction with the American
ociety of Nuclear Cardiology (10). The process for appro-
riateness criteria development is only partially evidence-
ased and is heavily weighted by expert consensus (8). The
riting committee examined 52 possible applications of
PECT, identifying 27 as appropriate indications, using an
rbitrary threshold value of 7 or greater on a scale of 9, and
3 as inappropriate indications, using a threshold value of 3
r less. Importantly, however, 12 applications (nearly 25%
f the total) achieved values ranging from 4 to 6 and were
eemed to have an “uncertain” indication.
The only means to determine whether these appropriateness
riteria are themselves appropriate as surrogates for quality is to
valuate them in clinical practice. The important study by
ibbons et al. (11) in this issue of the Journal is the first such
nvestigation to critically evaluate the American College of
ardiology Foundation/American Society of Nuclear Cardi-
logy appropriateness criteria for stress SPECT-MPI in the
etting of busy imaging laboratories at a large academic medical
enter. Gibbons et al. (11) demonstrate that the application of
hese criteria in practice, although desirable, may be met with
onsiderable challenges and difficulties. The authors point out
he many assumptions required to apply the criteria and,
espite these assumptions, the difficulty in determining appro-
riateness of testing in many patients, even in a large volume
ystem with an established database and highly experienced
urse abstracters. The nurse abstractors encountered difficulty
n categorizing many patients, in that 11%were not classifiable,
nd there was often lack of agreement among the nurses.
resumably, application of the criteria in the setting of a
maller clinical practice with fewer resources will be even more
roublesome.
Appropriateness criteria for echocardiography have also
een published recently using similar methodology (12), but
he criteria for stress echocardiography are still in development.
o assess how appropriateness criteria for stress echocardiog-
aphy might perform in practice, Gibbons et al. (11) extrapo-
ated the criteria for SPECT-MPI to their stress echocardiog-
aphy laboratory. Their results demonstrate a remarkably
oncordant degree of appropriate testing in nuclear cardiology
nd stress echocardiography (64% in both laboratories) and a
ow and similar degree of inappropriate testing (14% vs. 18%,
espectively). The similarity of appropriate and inappropriate
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April 1, 2008:1290–1 Editorial Commentesting between the nuclear and stress echocardiography labo-
atories is interesting, as is the similar number of unclassifiable
atients, but these results are also difficult to fully interpret. As
oted by the authors, applying the appropriateness criteria
esigned for nuclear stress testing to stress echocardiography
ay not be valid, and this represents a limitation of the study.
On the other hand, the finding that the vast majority of
nappropriate indications for testing were confined to only a
mall number of indications is quite important, because it
dentifies an opportunity for quality improvement and
ducational programs to achieve measurable improvement
n results. The report from Gibbons et al. (11) represents
he first step in the process of evaluating and refining the
trategy of using appropriateness criteria as a measure of
uality in cardiovascular imaging. Patients in this study
nderwent imaging before the appropriateness criteria were
ublished, and it is possible that different results might now
e obtained. Additional studies in other laboratories in
iverse practice settings should be encouraged as they will
ead to an iterative process in which the criteria are continually
efined and improved upon, thus with time becoming more
appropriate” as appropriateness criteria.
There is no doubt that imaging has transformed, and will
ontinue to transform, the practice of cardiovascular medi-
ine. The continuing advances in noninvasive imaging
reate a unique opportunity to improve diagnosis and
edical management, but also create challenges in patient
election, clinical training, integration with established clin-
cal practice, and resource utilization and cost effectiveness.
s a cardiovascular community we need to provide rigorous
vidence that imaging, and in particular appropriate imag-
ng, enhances quality of care.
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